| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
905 |
841 |
$99K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
890 |
836 |
$50K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
280 |
274 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
575 |
534 |
$30K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
192 |
187 |
$15K |
| 87634 |
|
206 |
199 |
$13K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
311 |
310 |
$11K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
104 |
103 |
$9K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
99 |
99 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
324 |
323 |
$4K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
379 |
379 |
$3K |
| 90461 |
|
109 |
109 |
$3K |
| 94760 |
|
1,434 |
1,280 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
131 |
131 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
62 |
59 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
24 |
24 |
$2K |
| 96127 |
|
188 |
188 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
18 |
18 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
95 |
93 |
$1K |
| 81002 |
|
308 |
302 |
$889.06 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
58 |
58 |
$744.89 |
| 92587 |
|
43 |
42 |
$727.02 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
21 |
18 |
$385.35 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
32 |
32 |
$350.40 |
| 99050 |
|
17 |
17 |
$281.52 |
| 99177 |
|
55 |
55 |
$204.60 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
15 |
$186.96 |